SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022495
Filing Date
2017-11-08
Accepted
2017-11-08 08:01:19
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itek-10q_20170930.htm 10-Q 1792590
2 EX-10.5 itek-ex105_260.htm EX-10.5 11855
3 EX-31.1 itek-ex311_6.htm EX-31.1 18220
4 EX-31.2 itek-ex312_8.htm EX-31.2 18214
5 EX-32.1 itek-ex321_7.htm EX-32.1 13755
  Complete submission text file 0001564590-17-022495.txt   7155785

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itek-20170930.xml EX-101.INS 1726411
7 XBRL TAXONOMY EXTENSION SCHEMA itek-20170930.xsd EX-101.SCH 40642
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itek-20170930_cal.xml EX-101.CAL 37438
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itek-20170930_def.xml EX-101.DEF 204719
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itek-20170930_lab.xml EX-101.LAB 365206
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itek-20170930_pre.xml EX-101.PRE 287261
Mailing Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 171185134
SIC: 2834 Pharmaceutical Preparations